GLP-1 Maintenance: Why Keeping Weight Off Is Harder | Dr. Leslie Golden & Dr. Robyn Pashby

What happens after the weight loss? For many people using GLP-1 medications like Zepbound, Wegovy, Mounjaro, or Ozempic, maintenance can become one of the hardest and most emotional parts of the journey. Weight loss may be celebrated publicly, but long-term obesity care raises difficult questions around biology, mindset, identity, fear of regain, dose adjustments, and what “success” actually means. In this episode of Weight & Measure with Mike and Zach, we are joined by Leslie Golden and Robyn Pashby for an honest conversation about GLP-1 maintenance through both the latest research and real-world clinical experience. We discuss: What the newest GLP-1 maintenance studies actually show Why many patients struggle after “successful” weight loss How doctors think about dose spacing, dose reduction, and long-term treatment The psychology of maintenance and fear of regain Identity shifts after major weight loss What happens when the scale stops moving Why obesity treatment is about more than just losing weight How patients can build a sustainable long-term approach to health Many patients who appear successful by traditional standards still struggle emotionally and psychologically during maintenance. Together, Dr. Pashby and Dr. Golden explore why long-term obesity care requires more than simply reaching a number on the scale. As always, Weight & Measure brings clinicians, researchers, and lived experience together in one conversation, with a live audience helping shape the discussion in real time. #GLP1 #ObesityCare #Maintenance #Zepbound #Wegovy #Mounjaro #Ozempic #WeightLoss #ObesityMedicine #FoodNoise